Journal
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
Volume 103, Issue 2, Pages 237-244Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.apmr.2021.07.812
Keywords
Prolotherapy; Rehabilitation; Rotator cuff; Tendinopathy
Categories
Funding
- Ministry of Science and Technology of Taiwan [MOST 105-2314-B-038-040, MOST 106-2314-B-038-027, TMU108-AE1-B01]
Ask authors/readers for more resources
This study investigated the effects of hypertonic dextrose injection on pain and disability in patients with chronic supraspinatus tendinosis. It found that the injection provided short-term pain and disability relief, as well as changes in tendon morphology.
Objectives: To investigate the effect of hypertonic dextrose injection on pain and disability in patients with chronic supraspinatus tendinosis. The secondary aim was to evaluate its effect on the tendon range of motion (ROM) and morphology. Design: Randomized double-blind placebo-controlled trial. Setting: Outpatient clinic. Participants: Individuals (N=57) with symptomatic chronic supraspinatus tendinosis. Interventions: Participants were randomly administered ultrasound-guided injections of 20% hypertonic dextrose (study group, n=29) or 5% normal saline (control group, n=28). Main Outcome Measures: The primary outcome measure was visual analog scale (VAS) scores for pain and Shoulder Pain and Disability Index (SPADI) scores. Secondary outcomes included the ROM and ultrasound examination findings of the supraspinatus tendon at baseline and at 2, 6, and 12 weeks postintervention. Results: The study group exhibited significant improvements in the VAS (mean difference [MD], -2.1; 95% confidence interval [CI], -2.7 to -1.4; P<.001) and SPADI (MD, -11.6; 95% CI, -16.5 to -6.7; P<.001) scores compared with baseline scores at week 2. However, the effect was not sustained to week 6. Flexion ROM increased at weeks 2 (MD, 14.1; 95% CI, 5.7-22.5; P<.001) and 6 (MD, 8.9; 95% CI, 2.4-15.4; P=.003) compared with baseline. The thickness of the supraspinatus tendon improved at weeks 6 (MD, .50; 95% CI, .26-.74; P<.001) and 12 (MD, .61; 95% CI, .37-.84; P<.001) compared with baseline. The ratio of histograms also improved at weeks 6 (MD, .19; 95% CI, .06-.32; P=.002) and 12 (MD, .26; 95% CI, .10-41; P<.001) compared with baseline. Conclusion: Hypertonic dextrose injection could provide short-term pain and disability relief in patients with chronic supraspinatus tendinosis. Ultrasound imaging at week 6 revealed changed tendon morphology. (C) 2021 by the American Congress of Rehabilitation Medicine
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available